-
Ensartinib, sold
under the
brand name Ensacove, is an anti-cancer
medication used for the
treatment of non-small cell lung cancer.
Ensartinib is an Anaplastic...
-
Tivozanib Toceranib Vandetanib ALK
Alectinib Brigatinib Ceritinib Crizotinib Ensartinib Lorlatinib RET inhibitors:
Entrectinib (ALK, ROS1, NTRK), ****ibatinib...
-
Tivozanib Toceranib Vandetanib ALK
Alectinib Brigatinib Ceritinib Crizotinib Ensartinib Lorlatinib RET inhibitors:
Entrectinib (ALK, ROS1, NTRK), ****ibatinib...
- (INN)
enramycin (INN)
enrofloxacin (INN)
Enropro Ensacove ensaculin (INN)
ensartinib (USAN, INN)
ensitrelvir (INN)
ensituximab (USAN)
Enspryng entacapone (INN)...
-
manufactured by
Takeda and is
marketed under the
brand name Alunbrig.
Ensartinib is a
second generation targeted therapy (trial drug X-396), manufactured...
-
inhibitors currently (or soon to be)
undergoing clinical trials include:
Ensartinib (Xcovery's X-396,
undergoing the eXalt3
Phase III
multicenter clinical...
-
Resolution Liquid Biopsy ****ay to
Monitor Response and
Resistance to
Ensartinib". www.businesswire.com. 2019-10-29.
Retrieved 2020-01-16. "PHYSICIAN SPOTLIGHT:...
